NCT00462852View on ClinicalTrials.gov

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

November 30, 2011

Conditions
Pancreatic CancerThromboembolism
Interventions
DRUG

dalteparin

DRUG

gemcitabine hydrochloride

OTHER

diagnostic laboratory biomarker analysis

Trial Locations (8)

HU8 9HE

Princess Royal Hospital at Hull and East Yorkshire NHS Trust, Hull

LA1 4RP

Royal Lancaster Infirmary, Lancaster

EC1A 7BE

Saint Bartholomew's Hospital, London

SW17 0QT

St. George's Hospital, London

ME16 9QQ

Maidstone Hospital, Maidstone

NG5 1PB

Nottingham City Hospital, Nottingham

YO12 6QL

Scarborough General Hospital, Scarborough

DN15 7BH

Scunthorpe General Hospital, Scunthorpe

All Listed Sponsors
lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT00462852 - Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter